Menu

Healthy Growth Starts Here

Frost & Sullivan’s Transformational Health practice has a powerhouse team of analysts and strategists covering all facets of this trillion-dollar industry.

OUR VISION

We analyze growth opportunities and competitive positioning for our clients, based on our years of expertise, combined with the voice of the customer, to identify the best strategies to succeed in a world where disruptions are occurring due to Care Delivery Transformation, Site of Care Evolution, Payment Transition to Value-based Care, New Market Entrants, Business Model Innovation and Cutting-edge Technologies.

ENGAGE

ACT

Book a complimentary one-hour session of Growth Strategy Dialog with our experts.

Knowledge Partners

Upcoming speaking engagements

Digital Health

Healthcare systems are undergoing dramatic structural changes that will impact every aspect of the way healthcare services are paid for and delivered, and the movement of care outside traditional settings is transforming medicine through digital health solutions.

Advanced Medical Technologies

In-depth coverage of the multitude of products and solutions used by providers across a typical clinical pathway, ranging from making a diagnosis, using the appropriate interventional or therapeutic approach and finally monitoring the subject through rehabilitation and convalescence.

Pharma 2.0

To achieve continued double digit growth and mitigate risks in R&D and manufacturing, pharma companies must gather actionable intelligence that will enable them to move rapidly from quantity-based, fee-for-service model to outcomes based contracts and adopt new digital platforms.

Clinical Diagnostics & Research Tools

The industry is witnessing significant disruptions around new regulations (PAMA implementation, deployment of laboratory developed tests) and move towards decentralized testing (home & retail type settings).

Critical Trends for Healthcare Transformation

Digital Health

Digital health leverages information technology to enable and deliver care across different settings in the care continuum to provide a digitized and connected world. It is a market centric to the convergence between healthcare and the information communication technology space.

Business Models & Services

Diminishing returns on investments made towards strategies for technical innovation, are putting pressure on healthcare companies to achieve growth objectives through radically evolving their business model.

Health Data Science

Robust analytics and insights from the structured and unstructured data sets currently expanding from patients, populations, life sciences, med tech, payers and other sources, can enable the solving of some of the most critical issues in the marketplace.

Future of Industries & Outlooks

Assessing a spectrum of market influencers, analysis captures likely near and long term competitive and market forecast scenarios. Comprehensive analysis provides insights into potential risks and opportunities resulting from expected changes.

Emerging Markets

Today geographical expansion goes beyond BRIC countries. Potential new opportunities lie within markets such as Mexico, Vietnam, Indonesia, S Africa, Nigeria, Middle East, and even Pakistan and Bangladesh.

Medical Technology Disruptors

Many acute and chronic conditions today have few treatment options beyond marginally mitigating disease progression and/or discomfort resulting from symptoms. Significant advances being made in biomedical engineering and medical research, are enabling a new generation of medical tools and technologies.

From Hospital to Home

Transitioning care delivery towards a model more focused on efficiency and effectiveness requires optimization of clinical workflows and decentralizing site of care. Reconciling population health management with individualized care can only occur through investment in new tools and infrastructure.

Precision Medicine

Precision medicine is a paradigm shift from broad therapies to targeted therapies and will transform clinical practice and treatment outcomes. Better understanding of disease heterogeneity and identification of novel targets will expand its application beyond oncology.

FEMTECH

With a market potentitial of $50 billion by 2025, Female Technology refers to software, diagnostics, products, and services that use technology to improve women’s health.

BLOCKCHAIN

Technology can introduce new business models and improve care coordination. Blockchain addrresses key challenges such as Cybersecurity threats and offers growth opportunities in precision medicine and value-based care.

ARTIFICIAL INTELLIGENCE

Mostly used to deal with the complexity and growth of medical data. Real-world benefits are automated disease prediction, personalization of treatment pathways, which promise to ensure higher profitability and sustain competitive advantage for payers, providers, and pharmaceutical enterprises.

New Technology Adoption

Healthcare has traditionally been a slow adopter of new technologies. We cut through the hype to assess the real impact, timing, and how to overcome competitive and customer challenges to succeed.

Have Questions?

We have Answers.

Schedule a Complimentary Growth Strategy
Dialogue with an Industry Expert

877.GoFrost

(877.463.7678)

myfrost@frost.com

X